Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450

Cancer Letters

Volumn 274, Issue 1, 2009, Pages 54-60

  Androutsopoulos, Vasilis ^a   Wilsher, Nicola ^a   Arroo, Randolph R J ^a   Potter, Gerry A ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

CYP1A1; CYP1B1; Flavone; MCF 7 cells; Natural products

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DIOSMETIN; ESTROGEN RECEPTOR; LUTEOLIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CELL; CELL LINE; CELL STRAIN MCF 7; CYTOTOXICITY; DEMETHYLATION; DRUG ACTIVATION; DRUG ACTIVITY; ENZYME ASSAY; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; FLAVONOIDS; HUMANS; LUTEOLIN; PHYTOESTROGENS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 57749091536     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.08.032     Document Type: Article

References (43)

1. World Cancer Research Fund/American Institute for Cancer Research, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, The Second Expert Report, AICR, Washington DC, 2007.
2. Rahman K.M., Sarkar F.H., Banerjee S., Wang Z., Liao D.J., Hong X., et al. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol. Cancer Ther. 5 (2006) 2747-2756
3. Squires M.S., Hudson E.A., Howells L., Sale S., Houghton C.E., Jones J.L., et al. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem. Pharmacol. 65 (2003) 361-376
4. Arroo R.R.J., Androutsopoulos V., Patel A., Surichan S., Wilsher N., and Potter G.A. Phytoestrogens as natural prodrugs in cancer prevention: a novel concept. Phytochem. Rev. 7 (2008) 431-443
5. Valko M., Rhodes C.J., Moncol J., Izakovic M., and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (2006) 1-40
6. Ishikawa Y., and Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int. 58 (2000) 1078-1087
7. Gopalakrishnan A., Xu C.J., Nair S.S., Chen C., Hebbar V., and Kong A.N. Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells. Arch. Pharm. Res. 8 (2006) 633-644
8. Kim H.J., Lee S.B., Park S.K., Kim H.M., Park Y.I., and Dong M.S. Effects of hydroxyl group numbers on the B-ring of 5, 7-dihydroxyflavones on the differential inhibition of human CYP1A and CYP1B1 enzymes. Arch. Pharm. Res. 28 (2005) 1114-1121
9. Chang T.K.H., Chen J., and Yeung E.Y.H. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: Identification of isorhamnetin, kaempherol, and quercetin as potent inhibitors of CYP1B1. Toxicol. Appl. Pharmacol. 213 (2006) 18-26
10. Shimada T., and Kuriyama Y.F. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 95 (2004) 1-6
11. Potter G.A., Patterson L.H., Wanogho E., Perry P.J., Butler P.C., Ijaz T., et al. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 86 (2002) 774-778
12. Sahu N.P., Achari B., and Banerjee S. 7,3′-Dihydroxy-4′-methoxyflavone from seeds of Acacia farnesiana. Phytochemistry 49 (1998) 1425-1426
13. Garavito G., Rincon J., Arteaqa L., Hata Y., Bourdy G., Gimenez A., et al. Antimalarial activity of some Colombian medicinal plants. J. Ethnopharmacol. 107 (2006) 460-462
14. Meirinhos J., Silva B.M., Valentao P., Seabra R.M., Pereira J.A., Dias A., et al. Analysis and quantification of flavonoidic compounds from Portuguese olive (Olea europaea L.) leaf cultivars. Nat. Prod. Res. 19 (2005) 189-195
15. Browning A.M., Walle U.K., and Walle T. Flavonoid glycosides inhibit oral cancer cell proliferation-role of cellular uptake and hydrolysis to the aglycones. J. Pharm. Pharmacol. 57 (2005) 1037-1042
16. Ciolino H.P., Wang T.T.Y., and Yeh G.C. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res. 58 (1998) 2754-2760
17. Doostdar H., Burke M.D., and Mayer R.T. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 144 (2000) 31-38
18. Döhr O., Vogel C., and Abel J. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Arch. Biochem. Biophys. 321 (1995) 405-412
19. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
20. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principles of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
21. Lin J.H. Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics. Drug Metab. Dispos. 26 (1998) 1202-1212
22. Cohen S.G., Chishti S.B., Bell D.A., Howard S.I., Salih E., and Cohen J.B. General occurrence of binding to acetylcholinesterase-substrate complex in noncompetitive inhibition and in inhibition by substrate. Biochim. Biophys. Acta 1076 (1991) 112-122
23. Mason M.G., Nicholls P., Wilson M.T., and Cooper C.E. Nitric oxide inhibition of respiration involves both competitive (heme) and non competitive (copper) binding to cytochrome c oxidase. Proc. Natl. Acad. Sci. USA 103 (2006) 708-713
24. Breinholt V.M., Offord E.A., Brouwer C., Nielsen S.E., Brøsen K., and Friedberg T. In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem. Toxicol. 40 (2002) 609-616
25. Otake Y., and Walle T. Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2 and CYP2C9. Drug Metab. Dispos. 30 (2002) 103-105
26. Piver B., Fer M., Vitrac X., Merrilon J.M., Dreano Y., Berthou F., et al. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem. Pharmacol. 68 (2004) 773-782
27. Murray G.I., Taylor M.C., McFadyen M.C.E., McKay J.A., Greenlee W.F., Burke M.D., et al. Tumour specific expression of cytochrome P450 CYP1B1. Cancer Res. 57 (1997) 3026-3031
28. Leung Y.K., Lau K.M., Mobley J., Jiang Z., and Ho S.M. Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesis. Cancer Res. 65 (2005) 3726-3734
29. Middleton Jr. E., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52 (2000) 673-751
30. Boutin J.A., Meunier F., Lambert P.H., Hennig P., Bertin D., Serkiz B., et al. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats. Drug Metab. Dispos. 21 (1993) 1157-1166
31. Simonetti P., Gardana C., Riso P., Mauri P., Pietta P., and Porrini M. Glycosylated flavonoids from tomato puree are bioavailable in humans. Nutr. Res. 25 (2005) 717-726
32. Fang J., Zhou Q., Shi X.L., and Jiang B.H. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis 28 (2007) 713-723
33. Selvendiran K., Koga H., Ueno T., Yoshida T., Maeyama M., Torimura T., et al. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res. 66 (2006) 4826-4834
34. Shi R.X., Ong C.N., and Shen H.M. Protein kinase C inhibition and X-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Cancer Res. 65 (2005) 7815-7823
35. Bagli E., Stefaniotou M., Morbidelli L., Ziche M., Psillas K., Murphy C., et al. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Res. 64 (2004) 7936-7946
36. Androutsopoulos V., Arroo R.R.J., Hall J.F., Surichan S., and Potter G.A. Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1 mediated metabolism. Breast Cancer Res. 10 (2008) R39
37. Brantley E., Trapani V., Alley M.C., Hose C.D., Bradshaw T.D., Stevens M.F.G., et al. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolised, and bind to macromolecules in sensitive human cancer cells. Drug Metab. Dispos. 32 (2004) 1392-1401
38. Atherton K., Mutch E., and Ford D. Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity. Biochem. Pharmacol. 72 (2006) 624-631
39. Bode A.M., and Dong Z. Molecular and cellular targets. Mol. Carcinogen. 45 (2006) 422-430
40. Tsuji P.A., and Walle T. Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis 27 (2006) 1579-1585
41. Wen X., and Walle T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26 (2005) 1774-1781
42. Loaiza-Pérez A.I., Kenney S., Boswell J., Hollingshead M., Alley M.C., Hose C., Ciolino H.P., et al. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Mol. Cancer Ther. 3 (2004) 715-725
43. Chua M.S., Kashiyama E., Bradshaw T.D., Stinson S.F., Brantley E., Sausville E.A., et al. Role of CYP1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl) benzothiazole (DF 203, NSC 674495) in human breast cancer cells. Cancer Res. 60 (2000) 5196-5203